Related Experiment Video
Updated: Mar 29, 2026
06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
9.3K
Elderly patients' participation in clinical trials
Premnath Shenoy1, Anand Harugeri1
1Regulatory Affairs and Patient Safety, AstraZeneca Pharma India Ltd., Bengaluru, Karnataka, India.
Perspectives in Clinical Research
|December 2, 2015
Summary
Elderly patients are underrepresented in clinical trials, leading to insufficient data on medication efficacy and safety in this demographic. Including older adults in studies is crucial for evidence-based geriatric medicine.
Area of Science:
- Geriatric Medicine
- Clinical Pharmacology
- Regulatory Science
Background:
- The global elderly population is rapidly expanding.
- Older adults represent a significant patient majority for chronic diseases like cancer, cardiovascular disease, and arthritis.
- Elderly individuals are primary users of medications for long-term health conditions.
Purpose of the Study:
- To highlight the critical need for including elderly patients in clinical trials.
- To address the inadequacy of data on geriatric patient responses to medications.
- To advocate for the removal of arbitrary age restrictions in clinical research.
Main Methods:
- Review of current clinical trial practices regarding age inclusion.
- Analysis of regulatory guidelines from developed countries and India.
- Discussion on the implications of excluding elderly participants.
Main Results:
- Elderly populations are significantly underrepresented in adult clinical trials (typically aged 18-64).
- This underrepresentation results in a lack of robust evidence for medication use in geriatric patients.
- Developed countries' regulatory bodies recommend against arbitrary age limits in trials.
Conclusions:
- Clinical trials must include diverse age groups to reflect real-world patient populations.
- Regulatory authorities, including India's CDSCO, should eliminate upper age limits in study protocols.
- Inclusion of elderly participants is essential for advancing safe and effective geriatric pharmacotherapy.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
347
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
347
01:16Clinical Trials
11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.1K
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
317
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
317
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
208
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
208
01:11Clinical Trials: Overview
5.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
324
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
324